Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MATCH: Preoperative Chemotherapy in Gastric/Gastroesophageal Cancer
NCT02725424Phase 2Completed
- Sponsor
- Chinese Academy of Medical Sciences
- Start
- Aug 2015
- Primary completion
- Dec 2018
- Modality
- Antibody Conjugates, Monoclonal Antibodies, Engineered Antibody Formats
- Countries
- 1
01
Overview
A Phase 2 trial of trastuzumab, docetaxel in gastric cancer (GC), gastroesophageal junction adenocarcinoma, sponsored by Chinese Academy of Medical Sciences. Started Aug 2015; status: completed.
02
Drugs
trastuzumabdocetaxel
03
Conditions
gastric cancer (GC)gastroesophageal junction adenocarcinoma
Beyond the preview
Go deeper on NCT02725424.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02725424.